Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dementia l: Introduction

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

Alzheimer Disease l: Introduction

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Salivary glucocorticoid receptor gene DNA methylation and cortisol output in relation to lifestyle, psychological distress, and cognition in university students.

Psychoneuroendocrinology·2026

Same author

Prevalence and incidence of balance disorders in community-dwelling older adults: Protocol for the EPIBAS epidemiological balance study.

PloS one·2026

Same author

Reframing Expectations about aging - Physical Activity and Inclusive Reappraisal (RE-PAIR): Protocol of a randomized intervention promoting positive self-perceptions of aging and physical activity in older couples.

BMC geriatrics·2026

Same author

Cross-sectional and longitudinal associations of self-perceptions of aging with physical activity in multimorbidity: The role of depressive symptoms.

Archives of gerontology and geriatrics·2026

Same author

CALM-VLM: CALIBRATION AND SELECTIVE PREDICTION IN VISION-LANGUAGE MODELS FOR RELIABLE BRAIN MRI CLASSIFICATION.

bioRxiv : the preprint server for biology·2026

Same author

Counterclockwise Virtual Reality-Based Embodiment of a Younger Self and Revisit of a Past Iconic Event in Older Adults: Between-Groups Study of Cognitive and Physical Performance.

JMIR formative research·2026

Search research articles

Related Experiment Video

Updated: Apr 24, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Cerebrovascular markers in lowered cognitive function.

Maria Mataró¹, Juan José Soriano-Raya², Jorge López-Olóriz¹

¹Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, Spain Institute for Brain, Cognition and Behavior (IR3C), University of Barcelona, Barcelona, Spain.

Journal of Alzheimer'S Disease : JAD

|September 6, 2014

Summary

Cerebrovascular disease markers are key for detecting cognitive decline risk. This review covers neuroimaging, sonographic, and blood markers for early identification in subclinical individuals.

Keywords:

Biomarkers MRI markers blood markers cerebrovascular disease cognitive impairment sonographic markers

More Related Videos

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Experiment Videos

Last Updated: Apr 24, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Using Retinal Imaging to Study Dementia

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Area of Science:

Neurology
Gerontology
Medical Diagnostics

Background:

Cerebrovascular disease (CVD) significantly contributes to age-related cognitive decline and dementia.
Early identification of individuals at high risk for cognitive decline is crucial.
In vivo markers aid in understanding CVD pathology and disease progression.

Purpose of the Study:

To review common cerebrovascular markers associated with cognitive decline in subclinical individuals.
To highlight the importance of these markers for early detection and intervention.

Main Methods:

Literature review of common cerebrovascular markers.
Focus on markers detectable in subclinical individuals.
Categorization of markers into neuroimaging, sonographic, and blood-based.

Main Results:

Identified key neuroimaging markers (e.g., white matter hyperintensities, lacunes).
Highlighted sonographic markers (e.g., carotid intima-media thickness).
Discussed relevant blood markers (e.g., inflammatory markers, endothelial dysfunction markers).

Conclusions:

Cerebrovascular markers are vital for early detection of cognitive decline risk.
Neuroimaging, sonographic, and blood markers offer valuable insights.
These markers can guide preventive strategies and patient monitoring.